SCHEMBL6230386

SCHEMBL6230386

CC(=O)O[C@H]1O[C@H](CO)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ CA2 P00918 8/20 0.47
▸ OGA O60502 1/20 0.45
▸ CA1 P00915 7/20 0.45
▸ CA12 O43570 6/20 0.45
▸ CA4 P22748 4/20 0.45
▸ CA5A P35218 4/20 0.45
▸ CA5B Q9Y2D0 4/20 0.45
▸ CA7 P43166 3/20 0.45
▸ P4HB P07237 1/20 0.41
▸ PDIA4 P13667 1/20 0.41
▸ PDIA3 P30101 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ NR3C1 P04150 1/20 0.40
▸ FYN P06241 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ ADRA2B P18089 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4619733 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL313683 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL13928976 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL9616862 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL3972810 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL4619592 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL8089407 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL314060 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL314061 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA
SCHEMBL1686174 1.00 CYP2D6 (0.51) CYP2D6THRBHSD17B10CA2OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782990-B1 METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES INNOVATION HAMMER LLC (US) 2020-10-07 — — EP claimed
US-10010029-B2 Methods and systems for growing plants using silicate-based substrates, cultivation of enhanced photosynthetic productivity and photosafening by utilization of exogenous glycopyranosides for endogenous glycopyranosyl-protein derivatives, and formulations, processes and systems for the same INNOVATION HAMMER, LLC (US) 2018-07-03 — — US claimed
US-20140331555-A1 Methods And Systems For Growing Plants Using Silicate-Based Substrates, Cultivation Of Enhanced Photosynthetic Productivity And Photosafening By Utilization Of Exogenous Glycopyranosides For Endogenous Glycopyranosyl-Protein Derivatives, And Formulations, Processes And Systems For The Same INNOVATION HAMMER, LLC 2014-11-13 — — US claimed
WO-2023028338-A2 MANNOSE 6-PHOSPHATE OR ASGPR RECEPTOR BINDING COMPOUNDS FOR THE DEGRADATION OF EXTRACELLULAR PROTEINS AVILAR THERAPEUTICS, INC. (US) 2023-03-02 — — WO disclosed
EP-3783093-A2 METHOD FOR GROWING PLANTS USING SILICATE MICROBEADS AND PHOTOSAFENING BY UTILIZATION OF EXOGENOUS GLYCOPYRANOSIDES Innovation Hammer LLC (US) 2021-02-24 — — EP disclosed
EP-0973886-B1 METHOD AND CONJUGATE FOR TREATING HELICOBACTER PYLORI INFECTIONS AVI BIOPHARM INC (US) 2005-03-23 — — EP disclosed
US-6124271-A ANTISENSE CONJUGATE STABLE TO STOMACH ENVIRONMENT AND COMPOSED OF AN UPTAKE FACILITATING TRANSPORT MOIETY CONJUGATED TO A NUCLEASE-RESISTANT ANTISENSE OLIGOMER WHICH BASE-SPECIFICALLY BINDS TO H. PYLORI MRNA TRANSCRIPT AVI BIOPHARMA, INC. 2000-09-26 — — US disclosed
US-4554349-A Aralkyl and aralkenyl glycosides as inhibitors of antigen-specific T-cell proliferation MERCK & CO., INC. (US) 1985-11-19 — — US disclosed
Send feedback